Literature DB >> 24385514

Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies.

Carlos Silvestre-Roig1, Menno P de Winther, Christian Weber, Mat J Daemen, Esther Lutgens, Oliver Soehnlein.   

Abstract

Understanding the pathophysiology of atherogenesis and the progression of atherosclerosis have been major goals of cardiovascular research during the previous decades. However, the complex molecular and cellular mechanisms underlying plaque destabilization remain largely obscure. Here, we review how lesional cells undergo cell death and how failed clearance exacerbates necrotic core formation. Advanced atherosclerotic lesions are further weakened by the pronounced local activity of matrix-degrading proteases as well as immature neovessels sprouting into the lesion. To stimulate translation of the current knowledge of molecular mechanisms of plaque destabilization into clinical studies, we further summarize available animal models of plaque destabilization. Based on the molecular mechanisms leading to plaque instability, we outline the current status of clinical and preclinical trials to induce plaque stability with a focus on induction of dead cell clearance, inhibition of protease activity, and dampening of inflammatory cell recruitment.

Entities:  

Keywords:  atherosclerosis; efferocytosis; macrophages; necrotic core; neutrophils

Mesh:

Substances:

Year:  2014        PMID: 24385514     DOI: 10.1161/CIRCRESAHA.114.302355

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  88 in total

Review 1.  Molecular imaging of plaque vulnerability.

Authors:  Sina Tavakoli; Aseem Vashist; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-08-15       Impact factor: 5.952

2.  Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution.

Authors:  Huachun Cui; Dingyuan Jiang; Sami Banerjee; Na Xie; Tejaswini Kulkarni; Rui-Ming Liu; Steven R Duncan; Gang Liu
Journal:  JCI Insight       Date:  2020-03-12

3.  Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis.

Authors:  Tessa J Barrett; Martin Schlegel; Felix Zhou; Mike Gorenchtein; Jennifer Bolstorff; Kathryn J Moore; Edward A Fisher; Jeffrey S Berger
Journal:  Sci Transl Med       Date:  2019-11-06       Impact factor: 17.956

4.  Basic research: Standardizing animal atherosclerosis studies to improve reproducibility.

Authors:  Oliver Soehnlein; Carlos Silvestre-Roig
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

Review 5.  Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.

Authors:  Gyu S Heo; Deborah Sultan; Yongjian Liu
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

Review 6.  [Atherothrombosis : Novel therapeutic strategies].

Authors:  O Soehnlein
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

7.  Relation between anti-atherosclerotic effects of IRAK4 and modulation of vascular smooth muscle cell phenotype in diabetic rats.

Authors:  Lijuan Cao; Defeng Pan; Dongye Li; Yanbin Zhang; Qiuping Chen; Tongda Xu; Wenhua Li; Wanling Wu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 8.  The Ins and Outs of Myeloid Cells in Atherosclerosis.

Authors:  Ariane Schumski; Carla Winter; Yvonne Döring; Oliver Soehnlein
Journal:  J Innate Immun       Date:  2018-04-18       Impact factor: 7.349

Review 9.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

10.  Phosphorylation of CHOP (C/EBP Homologous Protein) by the AMP-Activated Protein Kinase Alpha 1 in Macrophages Promotes CHOP Degradation and Reduces Injury-Induced Neointimal Disruption In Vivo.

Authors:  Xiaoyan Dai; Ye Ding; Zhaoyu Liu; Wencheng Zhang; Ming-Hui Zou
Journal:  Circ Res       Date:  2016-09-20       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.